Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001534969-22-000123
Filing Date
2022-08-10
Accepted
2022-08-10 16:13:04
Documents
74
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sera-20220630.htm   iXBRL 10-Q 1690188
2 EX-31.1 sera-20220630x10qxex311.htm EX-31.1 8196
3 EX-31.2 sera-20220630x10qxex312.htm EX-31.2 8130
4 EX-32.1 sera-20220630x10qxex321.htm EX-32.1 6257
  Complete submission text file 0001534969-22-000123.txt   7323034

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sera-20220630.xsd EX-101.SCH 50865
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sera-20220630_cal.xml EX-101.CAL 82335
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sera-20220630_def.xml EX-101.DEF 220585
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sera-20220630_lab.xml EX-101.LAB 601093
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sera-20220630_pre.xml EX-101.PRE 380860
68 EXTRACTED XBRL INSTANCE DOCUMENT sera-20220630_htm.xml XML 1241992
Mailing Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109
Business Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109 (801) 990-0520
SERA PROGNOSTICS, INC. (Filer) CIK: 0001534969 (see all company filings)

EIN.: 261911522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40606 | Film No.: 221151961
SIC: 8071 Services-Medical Laboratories